Acquired Hypothyroidism
Understand Acquired Hypothyroidism, also known as Hypothyroidism or Underactive Thyroid, with this guide for healthcare professionals. Learn about clinical documentation requirements, medical coding for Hypothyroidism (including ICD-10 codes), and diagnostic criteria for Acquired Hypothyroidism. This resource offers information on diagnosis, treatment, and management of Hypothyroidism for improved patient care and accurate medical records.
A condition where the thyroid gland doesn't produce enough thyroid hormone.
Fatigue, weight gain, constipation, dry skin, cold intolerance, depression.
Primary care, endocrinology, internal medicine.
ICD-10 Code Families
Complete code families applicable to E03.9
When to use each related code
| Description | When to use |
|---|---|
| Underactive thyroid, acquired after birth. | Use for hypothyroidism developing after the neonatal period. Exclude congenital causes. Consider Hashimoto's if autoimmune. |
| Underactive thyroid present at birth. | Use for hypothyroidism diagnosed in newborns. Specify etiology if known (e.g., thyroid dysgenesis). |
| Autoimmune thyroiditis causing hypothyroidism. | Use when hypothyroidism is caused by Hashimoto's disease. Confirmed by positive thyroid antibodies. |
Best-practice checklist
- ✓Document TSH, Free T4 levels
- ✓Specify cause if known (e.g., surgery, radiation, medication)
- ✓Record thyroid antibody tests (e.g., TPOAb, TgAb)
- ✓Document symptoms (e.g., fatigue, weight gain, constipation)
- ✓Include relevant medication history and treatment plan
Common pitfalls to avoid
Coding E03.9 (hypothyroidism, unspecified) instead of E03.8 (other specified hypothyroidism) when clinical details support acquired type.
Failing to document and code drug-induced hypothyroidism (E03.2) when medication is the causal factor.
Insufficient documentation of postpartum hypothyroidism (O99.0-) impacting accurate coding and reimbursement.
Best-practice tips
- 01Optimize CDI for E03.9, document cause of hypothyroidism.
- 02Code E03.9 for drug-induced, specify medication.
- 03For postpartum, code O90.82, exclude Sheehan's (E23.2).
- 04Monitor TSH, Free T4 for accurate diagnosis, comply with HEDIS.
- 05Document thyroid antibodies for autoimmune etiology, support E03.9.
Step-by-step checklist
- 1
Confirm TSH elevation (ICD-10 E03.9, E03.8) and low free T4.
- 2
Evaluate for secondary causes: pituitary MRI if indicated.
- 3
Document symptom onset, severity, & medication history.
- 4
Review for drug interactions affecting thyroid function tests.
- 5
Assess for contraindications to thyroid hormone replacement.
Ready-to-paste narrative
Patient presents with complaints consistent with acquired hypothyroidism, including fatigue, weight gain, cold intolerance, constipation, and dry skin. Symptoms onset has been gradual over the past six months. Patient denies any history of thyroid surgery or radiation therapy to the neck. Family history is positive for autoimmune disorders. Physical examination reveals bradycardia, dry skin, and mild non-pitting edema of the lower extremities. Thyroid gland is not palpable. Laboratory evaluation reveals elevated thyroid stimulating hormone (TSH) level and low free thyroxine (free T4) level, confirming the diagnosis of primary hypothyroidism. Differential diagnosis includes secondary hypothyroidism and other conditions causing similar symptoms, such as depression and anemia. Plan includes initiating levothyroxine therapy, starting at a low dose and titrating based on TSH levels. Patient education provided on medication management, potential side effects, and the importance of regular monitoring of thyroid function tests. Follow-up appointment scheduled in six weeks to assess response to therapy and adjust medication dosage as needed. ICD-10 code E03.9, Hypothyroidism, unspecified, is assigned. Medical billing codes for evaluation and management services, laboratory tests, and medication management will be applied based on the services rendered. This diagnosis and treatment plan were discussed with the patient, and the patient expressed understanding and agreement.
Common questions and answers
What are the most common causes of acquired hypothyroidism in adults, and how do their diagnostic workups differ?+
Acquired hypothyroidism in adults is primarily caused by Hashimoto's thyroiditis (autoimmune), iatrogenic hypothyroidism (resulting from radioactive iodine therapy, thyroidectomy, or certain medications), and iodine deficiency (less common in developed countries). Differentiating between these etiologies requires a nuanced approach. Hashimoto's is typically diagnosed through the presence of thyroid peroxidase (TPO) antibodies and thyroglobulin (Tg) antibodies, along with elevated TSH and low free T4 levels. Iatrogenic hypothyroidism is diagnosed based on patient history and medication review, while iodine deficiency is suspected based on dietary history and can be confirmed through urine iodine testing. Consider implementing a diagnostic algorithm that incorporates TSH, free T4, TPO antibody, and Tg antibody testing as a first step, followed by further investigation based on initial findings. Explore how incorporating ultrasound assessment of thyroid morphology can aid in the differentiation process.
How do I differentiate between subclinical hypothyroidism and overt hypothyroidism in patients, and when is treatment indicated for each?+
Subclinical hypothyroidism is characterized by mildly elevated TSH levels (typically between 4.0 and 10.0 mIU/L) with normal free T4 levels. Overt hypothyroidism presents with elevated TSH and low free T4 levels. While overt hypothyroidism typically requires levothyroxine treatment, the management of subclinical hypothyroidism is more nuanced and depends on factors such as the presence of TPO antibodies, symptoms, age, and comorbidities like cardiovascular disease. Treatment is often recommended for patients with TPO antibodies, goiter, or overt symptoms. Learn more about the ATA guidelines for the management of subclinical hypothyroidism which advocate for a patient-centered approach that considers individual risk factors and preferences. Consider implementing a shared decision-making process with patients to discuss the benefits and risks of treatment in subclinical cases.
What are the best strategies for monitoring levothyroxine therapy in patients with acquired hypothyroidism, including how to adjust dosages and address persistent symptoms despite normal TSH?+
Monitoring levothyroxine therapy involves regular assessment of TSH levels, typically every 6-8 weeks after dose adjustments until the target TSH is reached. Once stabilized, annual monitoring is usually sufficient. Dosage adjustments should be made in small increments, and patients should be educated on the importance of consistent medication adherence. If patients experience persistent symptoms despite achieving a normal TSH, consider investigating for factors such as poor medication absorption, medication interactions, or the presence of other medical conditions that can mimic hypothyroid symptoms. Explore how evaluating free T4 and free T3 levels, in addition to TSH, can offer valuable insights into the adequacy of levothyroxine replacement in such cases. Consider implementing a comprehensive assessment that encompasses patient-reported outcomes, medication review, and assessment for comorbid conditions.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.